Vynfinit gains European approval for treatment of platinum-...
Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer
Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in … Continued